Effective treatment of cobalamin deficiency with oral cobalamin

Blood

Volumn 92, Issue 4, 1998, Pages 1191-1198

  Kuzminski, Antoinette M ^a   Del Giacco, Eric J ^a   Allen, Robert H ^a   Stabler, Sally P ^a   Lindenbaum, John ^a  

^a Box B 170 ^*

Author keywords

[No Author keywords available]

Indexed keywords

COBALAMIN; CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; INTRINSIC FACTOR; METHYLMALONIC ACID;

ADULT; AGED; AMNESIA; ARTICLE; ATAXIA; ATROPHIC GASTRITIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; ERYTHROCYTE VOLUME; FEMALE; FOLIC ACID BLOOD LEVEL; FOLIC ACID DEFICIENCY; HUMAN; INTESTINE SURGERY; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; PARESTHESIA; PERNICIOUS ANEMIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STOMACH SURGERY; VITAMIN BLOOD LEVEL; VITAMIN DEFICIENCY;

EID: 0032529322     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.4.1191     Document Type: Article

References (47)

1. Chanarin I: The Megaloblastic Anemias (ed 2). Oxford, UK, Blackwell Scientific, 1979
2. Babior BM, Bunn HF: Megaloblastic anemias, in Isselbacher KJ, Braunwald E, Wilson JD, Martin JB, Fauci AS, Kasper DL (eds): Harrison's Principles of Internal Medicine (ed 13). New York, NY McGraw-Hill, 1994, p 1731
3. Lee GR: Megaloblastic and nonmegaloblastic macrocytic anemias, in Lee GR, Bithell TC, Foerster J, Athens JW, Lukens JN (eds): Wintrobe's Clinical Hematology (ed 9). Philadelphia, PA, Lea & Febiger, 1993, p 777
4. Jeejeebhoy KN: Nutrient requirements and nutrient deficiencies in gastrointestinal diseases, in Sleisenger MH, Fordtran JS (eds): Gastrointestinal Disease: Pathophysiology/Diagnosis/Management (ed 5). Philadelphia, PA, Saunders, 1993, p 2039
5. Lederle FA: Oral cobalamin for pernicious anemia: Medicine's best kept secret? J Am Med Assoc 265:94, 1991
6. 12 plasma absorption. J Clin Invest 36:1551, 1957
7. 60-labeled cyanocobalamin following a parenteral dose. J Lab Clin Med 53:525, 1959
8. 12 without intrinsic factor. Blood 9:473, 1954
9. 12. London, UK, The Children's Medical Charity, 1990, p 51
10. 12 without intrinsic factor. Acta MedScand 184:247, 1968
11. 12 without intrinsic factor in the treatment of pernicious anemia. Ann Intern Med 58:810, 1963
12. 12). Arch Intern Med 106:280, 1960
13. 12 by mouth in pernicious and nutritional macrocytic anaemia and sprue. Lancet 2:454, 1949
14. 12 in pernicious antemia. Lancet 2:1298, 1958
15. 12 in pernicious anaemia. I. Oral administration without a source of intrinsic factor. Br Med J 2:905, 1950
16. 12. J Lab Clin Med 38:84, 1951
17. 12. Am J Med 13:284, 1952
18. Conley LC, Krevans JR: Developments in the diagnosis and treatment of pernicious anemia. Ann Intern Med 43:758, 1955
19. 12 in the treatment of macrocytic anemias. Southern Med J 48:261, 1955
20. Magnus EM: Cobalamin and unsaturated transcobalamin values in pernicious anaemia: Relation to treatment. Scand J Haematol 36:457, 1986
21. Lindenbaum J, Savage DG, Stabler SP, Allen RH: Diagnosis of cobalamin deficiency: II. Relative sensitivities of serum cobalamin, methylmalonic acid, and total homocysteine concentrations. Am J Hematol 34:99, 1990
22. Savage DG, Lindenbaum J, Stabler SP, Allen RH: Sensitivity of serum methylmalonic acid and total homocysteine determinations for diagnosing cobalamin and folate deficiencies. Am J Med 96:239, 1994
23. Lindenbaum J, Rosenberg IH, Wilson PWF, Stabler SP, Allen RH: Prevalence of cobalamin deficiency in the Framingham elderly population. Am J Clin Nutr 60:2, 1994
24. 12 binding capacity. Blood 25:875, 1965
25. Allen RH, Stabler SP, Savage DG, Lindenbaum J: Metabolic abnormalities in cobalamin (vitamin B-12) and folate deficiency. FASEB J 7:1344, 1993
26. Snedecor GW, Cochran WG: Statistical Methods. Ames, IA, Iowa University, 1973
27. 12 in patients with hypochlorhydria and achlorhydria and after gastric resection. Gastroenterology 64:913, 1973
28. Carmel R: Subtle and atypical cobalamin deficiency states. Am J Hematol 34:108, 1990
29. Westerveld BD, Pals G, Lamers CBHW, Defize J, Pronk JC, Frants RR, Ooms EC, Kreuning J, Kostense PJ, Eriksson AW: Clinical significance of pepsinogen A isozymogens, serum pepsinogen A and C levels, and serum gastrin levels. Cancer 59:952, 1987
30. Carmel R: Pepsinogens and other serum markers in pernicious anemia. Am J Clin Pathol 90:442, 1988
31. Kekki M, Samloff IM, Vans K, Ihamaki T: Serum pepsinogen I and serum gastrin in the screening of severe atrophie corpus gastritis. Scand J Gastroenterol 26:109, 1991 (suppl 186)
32. Steinberg WM, King CE, Toskes PP: Malabsorption of protein-bound cobalamin but not unbound cobalamin during cimetidine administration. Dig Dis Sci 25:188, 1980
33. Schenk BE, Festen HPM, Kuipers EJ, Klinkenberg-Knol EC, Meuwissen SGM: Effect of short- and long-term treatment with omeprazole on the absorption and serum levels of cobalamin. Aliment Pharmacol Ther 10:541, 1996
34. Stabler SP, Allen RH, Savage DG, Lindenbaum J: Clinical spectrum and diagnosis of cobalamin deficiency. Blood 76:871, 1990
35. Schilling RG: Pernicious anemia. J Am Med Assoc 253:94, 1985
36. Pennypacker LC, Allen RH, Kelly JP, Matthews LM, Grigsby J, Kaye K, Lindenbaum J, Stabler SP: High prevalence of cobalamin deficiency in elderly outpatients. J Am Geriatr Soc 40:1197, 1992
37. Guttormsen AB, Ueland PG, Nesthus I, Nygard O, Schneede J, Vollset SE, Refsum H: Determinants and vitamin responsiveness of intermediate hyperhomocysteinemia (>40 μmol/liter). J Clin Invest 98:2174, 1996
38. 12 and Intrinsic Factor 2. Europaisches Symposion. Stuttgart, Germany, Ferdinand Enke Verlag, 1962, p 737
39. 12 levels in patients with megaloblastic anaemia treated with folie acid. J Clin Pathol 15:274, 1962
40. Alien RH, Stabler SP, Savage D, Lindenbaum J: Diagnosis of cobalamin deficiency. I. Usefulness of serum methylmalonic acid and total homocysteine concentrations. Am J Hematol 34:90, 1990
41. Landgren P, Israelsson B, Lindgren A, Hultberg B, Andersson A, Brattstrom L: Plasma homocysteine in acute myocardial infarction: Homocysteine-lowering effect of folic acid. J Intern Med 237:381, 1995
42. 12 without intrinic factor. N Engl J Med 253:502, 1955
43. Hathcock JN, Troendle GJ: Oral cobalamin for treatment of pernicious anemia? J Am Med Assoc 265:96, 1991
44. 12 injections. Br Med J 291:56, 1985
45. 12 injections: Considerable source of work for the district nurse. Br Med J 290:1254, 1985
46. Savage D, Lindenbaum J: Relapses after interruption of cyanocobalamin therapy in patients with pernicious anemia. Am J Med 74:765, 1983
47. 12 body stores during oral and parenteral treatment of pernicious anemia. Acta Med Scand 204:81, 1978